Jihane Khalife

<i>RUNX1</i> Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression Signatures

Jason H. Mendler, Kati Maharry, Michael D. Radmacher et al. · Journal of Clinical Oncology · 2012 · 268 citations

Medicine, Cancer Biology, Oncology +17

Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia

Adrienne M. Dorrance, Paolo Neviani, Gregory Ferenchak et al. · Leukemia · 2015 · 121 citations · Full text

Pharmacy, Oncology, Pharmaceutics +16

Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting

Domenico Viola, Ada Donà, Enrico Caserta et al. · Leukemia · 2020 · 88 citations · Full text

Life Sciences, Immunology, Oncology +16

Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia

Jihane Khalife, Hanna S. Radomska, Ramasamy Santhanam et al. · Leukemia · 2015 · 81 citations · Full text

Life Sciences, Molecular Biology, Oncology +15

Copper 64–labeled daratumumab as a PET/CT imaging tracer for multiple myeloma

Enrico Caserta, Junie Chea, Megan Minnix et al. · Blood · 2018 · 72 citations · Full text

Medicine, Nuclear Medicine, Oncology +16